Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, of any gender
- People who have been diagnosed with epilepsy, based on a neurologist's assessment or brainwave test (EEG) results
- People who are experiencing symptoms of anxiety or depression
- People who are currently receiving neurological care at Atrium Health
- People who are willing to follow all study procedures and sign a consent form
Who may not be able to join:
- People who are currently taking part in another treatment or intervention study
- People whose cognitive difficulties would prevent them from completing anxiety and depression questionnaires — whether on paper, electronically, or through an interview
- People who have a serious medical condition where life expectancy is less than 6 months
- People who are already being actively treated by a psychiatrist
- People who are currently having thoughts of suicide
- People who have previously attempted suicide AND are currently receiving ongoing therapy, OR have seen a psychiatrist in the past year
- People who have attempted suicide in the past year AND are currently prescribed two or more psychiatric medications (not just for sleep), AND where the trial investigators do not consider collaborative care to be appropriate
- People with ongoing unstable drug or alcohol misuse
Important: Always verify eligibility with the trial site directly before applying.
Note: A separate part of this trial (called the sustainability supplement) also allows participation for people who have completed the control arm of a related study, or people who meet similar criteria but have a diagnosis of functional neurological disorder with seizures rather than epilepsy. Please confirm details about this with the trial site directly.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Heidi M Munger Clary, MPH, Wake Forest University Health Sciences
Phone: 336.716.9632
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change in emotional quality of life subscale of the Quality of Life in Epilepsy Inventory (QOLIE-31) - between two groups
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.